ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,287.60
      -0.24%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.135
      0.00%
      Bitcoin
      63,141.01
      -0.10%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Taysha Gene Therapies Inc (TSHA)

      7. Taysha Gene Therapies Inc (TSHA) News

      TSHA

      Taysha Gene Therapies (TSHA)

      Taysha Gene Therapies Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TSHA
      DateTimeSourceHeadlineSymbolCompany
      09/06/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      08/12/20248:32AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
      08/12/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
      08/12/20248:01AMGlobeNewswire Inc.Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
      08/05/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12NASDAQ:TSHATaysha Gene Therapies Inc
      08/02/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      07/05/20245:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
      07/05/20245:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
      07/05/20245:49PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
      07/05/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      06/26/20249:14AMGlobeNewswire Inc.Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
      06/25/20246:34PMGlobeNewswire Inc.Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
      06/18/20247:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
      06/18/20247:30AMGlobeNewswire Inc.Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
      06/07/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      05/31/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
      05/30/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
      05/14/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
      05/14/20244:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
      05/14/20244:01PMGlobeNewswire Inc.Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
      05/07/20244:05PMGlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14NASDAQ:TSHATaysha Gene Therapies Inc
      05/03/20244:05PMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      05/02/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
      04/05/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      03/20/20241:30PMAllPennyStocks.comAnother Biotech Steals The Show Following Major Clinical Data ReleaseNASDAQ:TSHATaysha Gene Therapies Inc
      03/19/20244:01PMGlobeNewswire Inc.Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
      03/19/20247:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:TSHATaysha Gene Therapies Inc
      03/14/20244:26PMGlobeNewswire Inc.Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19NASDAQ:TSHATaysha Gene Therapies Inc
      03/01/20245:08PMGlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
      02/29/20248:00AMGlobeNewswire Inc.Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
       Showing the most relevant articles for your search:NASDAQ:TSHA